Terms: = Breast cancer AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
259 results:
1. Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS.
Chairunnisa DF; Harahap Y; Juanita M; Syafhan NF; Purwanto DJ
Pak J Biol Sci; 2024 Mar; 27(3):125-131. PubMed ID: 38686734
[TBL] [Abstract] [Full Text] [Related]
2. Changes in lymph node surgery in breast cancer and preoperative drug prescription analysis for postoperative pain management: A retrospective, cross-sectional study.
Kang ES; Lim YC; Jang BH; Lee YJ; Ha IH; Lee YS
PLoS One; 2024; 19(4):e0298270. PubMed ID: 38574043
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of applying preoperative breast ultrasound and clinicopathologic features to predict axillary lymph node burden in early invasive breast cancer: a study of 1247 patients.
Shao H; Sun Y; Na Z; Jing H; Li B; Wang Q; Zhang C; Cheng W
BMC Cancer; 2024 Jan; 24(1):112. PubMed ID: 38254060
[TBL] [Abstract] [Full Text] [Related]
4. Health effects associated with exposure to secondhand smoke: a Burden of Proof study.
Flor LS; Anderson JA; Ahmad N; Aravkin A; Carr S; Dai X; Gil GF; Hay SI; Malloy MJ; McLaughlin SA; Mullany EC; Murray CJL; O'Connell EM; Okereke C; Sorensen RJD; Whisnant J; Zheng P; Gakidou E
Nat Med; 2024 Jan; 30(1):149-167. PubMed ID: 38195750
[TBL] [Abstract] [Full Text] [Related]
5. atrx is a predictive marker for endocrinotherapy and chemotherapy resistance in HER2-/HR+ breast cancer through the regulation of the AR, GLI3 and GATA2 transcriptional network.
Qian H; Ji R; Shen C; Wei Y; Sheng C; Ni Q; Pan J; Chi Y; You H; Miao Y; Shi M; Huang X; Shen A
Aging (Albany NY); 2023 Dec; 15(24):14996-15024. PubMed ID: 38126976
[TBL] [Abstract] [Full Text] [Related]
6. Expression of neuroendocrine markers predicts increased survival in triple-negative breast cancer patients.
Xia C; Shen S; Pang J; Chen L; Yan J; Liang Z; Ren X
Front Endocrinol (Lausanne); 2023; 14():1205631. PubMed ID: 38125789
[TBL] [Abstract] [Full Text] [Related]
7. A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer.
Mayer EL; Tayob N; Ren S; Savoie JJ; Spigel DR; Burris HA; Ryan PD; Harris LN; Winer EP; Burstein HJ
Breast Cancer Res Treat; 2024 Feb; 204(1):123-132. PubMed ID: 38019444
[TBL] [Abstract] [Full Text] [Related]
8. Association of ABCG2 Polymorphisms on Triple Negative breast cancer (TNBC) Susceptibility Risk.
Hao Ing Y; Md Salleh MS; Yahya MM; Ankathil R; Abdul Aziz AA
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3891-3897. PubMed ID: 38019248
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of factors influencing the pathological complete remission (ipCR) in patients with internal mammary lymph node metastasis after neoadjuvant chemotherapy.
Li Y; Fei Y
PeerJ; 2023; 11():e16141. PubMed ID: 37818328
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
11. cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.
He S; Xia C; Li H; Cao M; Yang F; Yan X; Zhang S; Teng Y; Li Q; Chen W
Sci China Life Sci; 2024 Jan; 67(1):122-131. PubMed ID: 37755589
[TBL] [Abstract] [Full Text] [Related]
12. Value of breast MRI and Nomogram After Negative Axillary Ultrasound for Predicting Axillary Lymph Node Metastasis in Patients With Clinically T1-2 N0 breast cancer.
Song SE; Cho KR; Cho Y; Jung SP; Park KH; Woo OH; Seo BK
J Korean Med Sci; 2023 Aug; 38(34):e251. PubMed ID: 37644678
[TBL] [Abstract] [Full Text] [Related]
13. Effects of occupational therapy on quality of life in breast cancer patients: A systematic review and meta-analysis.
He K; Jiang J; Chen M; Wang T; Huang X; Zhu R; Zhang Z; Chen J; Zhao L
Medicine (Baltimore); 2023 Aug; 102(31):e34484. PubMed ID: 37543817
[TBL] [Abstract] [Full Text] [Related]
14. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract] [Full Text] [Related]
15. Seroma After breast Reconstruction With Tissue Expanders: Outcomes and Management.
Ozturk CN; Ozturk C; Magner WJ; Ali A; Diehl J; Sigurdson SL
Ann Plast Surg; 2023 Sep; 91(3):331-336. PubMed ID: 37347178
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemical Characterization of a Large Cohort of Triple Negative breast cancer.
Han R; Nofech-Mozes S; Boles D; Wu H; Curcin N; Slodkowska E
Int J Surg Pathol; 2024 Apr; 32(2):239-251. PubMed ID: 37306115
[No Abstract] [Full Text] [Related]
17. Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer.
Villacampa G; Tung NM; Pernas S; Paré L; Bueno-Muiño C; Echavarría I; López-Tarruella S; Roche-Molina M; Del Monte-Millán M; Marín-Aguilera M; Brasó-Maristany F; Waks AG; Pascual T; Martínez-Sáez O; Vivancos A; Conte PF; Guarneri V; Vittoria Dieci M; Griguolo G; Cortés J; Llombart-Cussac A; Muñoz M; Vidal M; Adamo B; Wolff AC; DeMichele A; Villagrasa P; Parker JS; Perou CM; Fernandez-Martinez A; Carey LA; Mittendorf EA; Martín M; Prat A; Tolaney SM
Ann Oncol; 2023 Sep; 34(9):783-795. PubMed ID: 37302750
[TBL] [Abstract] [Full Text] [Related]
18. Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations.
Miyashita M; Bell JSK; Wenric S; Karaesmen E; Rhead B; Kase M; Kaneva K; De La Vega FM; Zheng Y; Yoshimatsu TF; Khramtsova G; Liu F; Zhao F; Howard FM; Nanda R; Beaubier N; White KP; Huo D; Olopade OI
Breast Cancer Res; 2023 May; 25(1):58. PubMed ID: 37231433
[TBL] [Abstract] [Full Text] [Related]
19. Association between environmental cadmium exposure and increased mortality in the U.S. National Health and Nutrition Examination Survey (1999-2018).
Moon S; Lee J; Yu JM; Choi H; Choi S; Park J; Choi K; Kim E; Kim H; Kim MJ; Park YJ
J Expo Sci Environ Epidemiol; 2023 Nov; 33(6):874-882. PubMed ID: 37161056
[TBL] [Abstract] [Full Text] [Related]
20. Exacerbated central fatigue and reduced exercise capacity in early-stage breast cancer patients treated with chemotherapy.
Hucteau E; Mallard J; Pivot X; Schott R; Pflumio C; Trensz P; Favret F; Pagano AF; Hureau TJ
Eur J Appl Physiol; 2023 Jul; 123(7):1567-1581. PubMed ID: 36939876
[TBL] [Abstract] [Full Text] [Related]
[Next]
